Chromatography and Sports Doping
The Victoria Advocate (Victoria, TX) published an article about the random testing of high school student-athletes in the Texas public school system. The article is entitled "No Steroid Test is Foolproof" and focuses on the process of drug testing using gas chromatography-mass spectroscopy (GC-MS).
The Victoria Advocate (Victoria, TX) published an article about the random testing of high school student-athletes in the Texas public school system. The article is entitled "No Steroid Test is Foolproof" and focuses on the process of drug testing using gas chromatography-mass spectroscopy (GC-MS).
Detection of banned substances such as steroids and HGH in sports is a growing segment of the bioseparations industry. Techniques for detecting these substances are continuously evolving and becoming more sophisticated. There are some substances such as human growth hormone (HGH) that efficient separation techniques have yet to be developed.
LCGC technical editor Steve Brown recently answered a reader's question about which chromatographic techniques are used in sports doping in a recent Ask the Editor column. LCGC associate editor Andrew Wiecek discussed the future of steroids detection by LC-MS in urine samples in LCGC's coverage of Pittcon 2007.
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.
